| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020743993 |
| P356 | DOI | 10.1038/GENE.2010.32 |
| P8608 | Fatcat ID | release_csg6upvmljfxrb7xx5zield26q |
| P698 | PubMed publication ID | 20535136 |
| P5875 | ResearchGate publication ID | 44660728 |
| P2093 | author name string | A A Sinha | |
| A B Coda | |||
| K Seiffert-Sinha | |||
| V Qafalijaj Hysa | |||
| P2860 | cites work | Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata | Q24680203 |
| Wnt signaling induces epithelial differentiation during cutaneous wound healing | Q25257722 | ||
| beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin | Q28190343 | ||
| Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy | Q28213440 | ||
| Hair follicle apoptosis and Bcl-2 | Q28512906 | ||
| Deficiency of small GTPase Rac2 affects T cell activation | Q28586146 | ||
| Characterization of Wnt gene expression in developing and postnatal hair follicles and identification of Wnt5a as a target of Sonic hedgehog in hair follicle morphogenesis | Q28591573 | ||
| beta-catenin is a target for the ubiquitin-proteasome pathway | Q29547589 | ||
| Alopecia areata: an autoimmune disease? | Q33760769 | ||
| Alopecia areata update | Q33869221 | ||
| Controls of hair follicle cycling | Q33930902 | ||
| The JNK and P38 MAP kinase signaling pathways in T cell-mediated immune responses | Q33989837 | ||
| IL-6 in autoimmune disease and chronic inflammatory proliferative disease | Q34148654 | ||
| Congenital alopecia areata | Q34391096 | ||
| Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation | Q34502385 | ||
| Cyclic dermal BMP signalling regulates stem cell activation during hair regeneration | Q34737529 | ||
| Role of complement in the development of autoimmunity | Q34984423 | ||
| GTPases and T cell activation | Q35096692 | ||
| The Hair Follicle and Immune Privilege | Q35569804 | ||
| Alopecia areata registry: an overview | Q35569829 | ||
| Complement receptor 2 and autoimmunity | Q35627080 | ||
| Identification of molecular biomarkers for multiple sclerosis | Q35789583 | ||
| Transient activation of beta -catenin signaling in cutaneous keratinocytes is sufficient to trigger the active growth phase of the hair cycle in mice. | Q35965329 | ||
| Genes and goals: an approach to microarray analysis in autoimmunity | Q36246855 | ||
| Alopecia areata: a tissue specific autoimmune disease of the hair follicle | Q36336272 | ||
| A network-based analysis of allergen-challenged CD4+ T cells from patients with allergic rhinitis. | Q36529802 | ||
| DNA microarray technology in dermatology | Q37166215 | ||
| Regular articles: conditional disruption of hedgehog signaling pathway defines its critical role in hair development and regeneration | Q39574805 | ||
| HLA and ICAM-1 expression in alopecia areata in vivo and in vitro: the role of cytokines | Q41660416 | ||
| Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection | Q43717040 | ||
| Is topical tacrolimus effective in alopecia areata universalis? | Q44201115 | ||
| Topical tacrolimus (FK506): treatment failure in four cases of alopecia universalis | Q44215691 | ||
| Topical tacrolimus in alopecia areata | Q45207665 | ||
| Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Q46522917 | ||
| Profile of alopecia areata: a questionnaire analysis of patient and family | Q46913897 | ||
| Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans. | Q51601347 | ||
| Reduced CD4+ T-cell-specific gene expression in human type 1 diabetes mellitus. | Q53569396 | ||
| Familial aggregation of alopecia areata | Q57655397 | ||
| Alopecia Areata in Families: Association with the HLA Locus | Q61181509 | ||
| Identical twins with identical alopecia areata | Q67578967 | ||
| Prevalence of alopecia areata in the First National Health and Nutrition Examination Survey | Q68109690 | ||
| Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis | Q68412284 | ||
| Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy | Q68757908 | ||
| Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis) | Q70363131 | ||
| Changes in populations of HLA-DR+CD3+ cells and CD57-CD16+ cells in alopecia areata after corticosteroid therapy | Q71614987 | ||
| Prevalence of thyroid diseases in patients with alopecia areata | Q71990987 | ||
| Topical tacrolimus: treatment failure in a patient with alopecia areata | Q73347294 | ||
| Congenital alopecia areata | Q73616699 | ||
| Alopecia areata and cytomegalovirus infection in twins: genes versus environment? | Q74371926 | ||
| ALOPECIA AREATA. AN EVALUATION OF 736 PATIENTS | Q76499988 | ||
| Suppression of hair follicle development inhibits induction of sonic hedgehog, patched, and patched-2 in hair germs in mice | Q77394251 | ||
| Essential role for Sonic hedgehog during hair follicle morphogenesis | Q77771288 | ||
| Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack | Q80413604 | ||
| Identical alopecia areata in identical twins | Q80610821 | ||
| Alopecia areata induced by adjuvant treatment with alpha-interferon in malignant melanoma? | Q80810438 | ||
| Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus | Q81163747 | ||
| P433 | issue | 7 | |
| P921 | main subject | heritability | Q1503548 |
| alopecia areata | Q5075435 | ||
| P304 | page(s) | 531-541 | |
| P577 | publication date | 2010-06-10 | |
| P1433 | published in | Genes and Immunity | Q15745246 |
| P1476 | title | Peripheral blood gene expression in alopecia areata reveals molecular pathways distinguishing heritability, disease and severity | |
| P478 | volume | 11 |
| Q64102174 | Analyses of Skin and Peripheral Blood Transcriptional Data in Cutaneous Lupus Reveals CCR2-A Novel Potential Therapeutic Target |
| Q31020150 | Big Data, Big Opportunities, and Big Challenges |
| Q26750589 | Emerging Role and Therapeutic Implication of Wnt Signaling Pathways in Autoimmune Diseases |
| Q39359711 | Genome-wide expression analysis suggests unique disease-promoting and disease-preventing signatures in Pemphigus vulgaris |
| Q86117481 | Genome-wide transcriptional profiling of chronic cutaneous lupus erythematosus (CCLE) peripheral blood identifies systemic alterations relevant to the skin manifestation |
| Q38832111 | Genomewide differential expression profiling of long non-coding RNAs in androgenetic alopecia in a Chinese male population |
| Q53217197 | Integration of genome-wide transcriptional and genetic profiles provides insights into disease development and clinical heterogeneity in alopecia areata. |
| Q38943432 | Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo |
| Q53112043 | Prior facility affects alopecia in adulthood for rhesus macaques. |
| Q53318728 | Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures. |
| Q38061795 | Update on the genetics of androgenetic alopecia, female pattern hair loss, and alopecia areata: implications for molecular diagnostic testing |
Search more.